GRAPPA 2021 年会皮肤研究工作组报告。

Report of the Skin Research Working Groups from the GRAPPA 2021 Annual Meeting.

机构信息

J.E. Yousif, A.B. Gottlieb, MD, PhD, Department of Dermatology, Icahn School of Medicine at Mount Sin ai, New York, New York.

J.F. Merola, MD, MMSc, Department of Dermatology and Medicine, Division of Rheumatology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts;

出版信息

J Rheumatol. 2022 Jun;49(6 Suppl 1):40-43. doi: 10.3899/jrheum.211328. Epub 2022 Apr 1.

DOI:10.3899/jrheum.211328

PMID:35365577

Abstract

The International Dermatology Outcome Measures (IDEOM) initiative presented an update on their progress related to instruments for psoriasis (PsO) and psoriatic arthritis (PsA) patient-centered outcome measures at the 2021 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). The Treatment Satisfaction working group presented the development of a 7-item treatment satisfaction questionnaire specific for dermatological conditions. The group is beginning by assessing the validity and reliability of the instrument in PsO patient populations, with the ultimate goal of validating it for use in multiple dermatological diseases. The Musculoskeletal Symptoms working group discussed how implementation of a screening measurement tool in patients with PsO can help identify unknown diagnoses of PsA or prevent worsening of symptoms.

摘要

国际皮肤病结局测量倡议（IDEOM）在 2021 年银屑病和银屑病关节炎研究与评估团体（GRAPPA）年会上，就其在银屑病（PsO）和银屑病关节炎（PsA）患者为中心的结局测量工具方面的进展进行了更新。治疗满意度工作组提出了一种专门针对皮肤病的 7 项治疗满意度问卷的开发。该小组首先评估该工具在 PsO 患者人群中的有效性和可靠性，最终目标是将其验证用于多种皮肤病。肌肉骨骼症状工作组讨论了在 PsO 患者中实施筛查测量工具如何有助于识别未知的 PsA 诊断或防止症状恶化。